EVOLYSSE Trademark

Trademark Overview

On Tuesday, May 9, 2023, a trademark application was filed for EVOLYSSE with the United States Patent and Trademark Office. The USPTO has given the EVOLYSSE trademark a serial number of 97928091. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Friday, May 30, 2025. This trademark is owned by Evolus, Inc.. The EVOLYSSE trademark is filed in the Pharmaceutical Products category with the following description:

Injectable dermal fillers
evolysse

General Information

Serial Number97928091
Word MarkEVOLYSSE
Filing DateTuesday, May 9, 2023
Status731 - SECOND EXTENSION - GRANTED
Status DateFriday, May 30, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 9, 2024

Trademark Statements

Goods and ServicesInjectable dermal fillers

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 7, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEvolus, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewport Beach, CA 92660
Party NameEvolus, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewport Beach, CA 92660

Trademark Events

Event DateEvent Description
Thursday, November 16, 2023NON-FINAL ACTION E-MAILED
Friday, May 12, 2023NEW APPLICATION ENTERED
Wednesday, June 7, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 8, 2023ASSIGNED TO EXAMINER
Thursday, November 16, 2023NON-FINAL ACTION WRITTEN
Thursday, November 16, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 7, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 7, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 7, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 7, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 20, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 9, 2024PUBLISHED FOR OPPOSITION
Tuesday, June 4, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 4, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, December 4, 2024SOU EXTENSION 1 GRANTED
Wednesday, December 4, 2024SOU EXTENSION 1 FILED
Thursday, December 5, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 10, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 10, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 10, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, February 10, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 14, 2025ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, April 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, May 30, 2025SOU TEAS EXTENSION RECEIVED
Friday, May 30, 2025SOU EXTENSION 2 FILED
Friday, May 30, 2025SOU EXTENSION 2 GRANTED
Monday, September 15, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 8, 2025TEAS STATEMENT OF USE RECEIVED

Related Keywords

evolysse fillers dermal injectable